Read More

Genetic Technologies Named Tony Di Pietro as CFO

Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE) is pleased to announce the appointment of experienced Chief Financial Officer, Mr Tony Di Pietro. Tony will also be appointed as Company Secretary upon his arrival. Mr Di Pietro is a Chartered Accountant and an Associate of the Governance Institute Australia with 18 years Biotechnology industry experience.

GENE

Read More

Genetic Technologies Announced Partnership With Siles Health to Bring GeneType Risk Test to 9 Clinics

Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, "Company", "GTG"), a global leader in genomics-based tests in health, wellness and serious disease is delighted to announce that we are partnering with Melbourne based Siles Health, a leading Obstetrics and Gynaecology practice, to implement geneType Multi-Risk Test as part of their commitment to remain at the forefront of contemporary personal

GENE